Nexus Announces Repricing of Warrants
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) has announced the repricing of 2,887,114 common share purchase warrants. The warrants, originally set at an exercise price of $0.60 with an expiry date of June 25, 2026, will be repriced to $0.36, effective immediately. This Warrant Repricing is subject to unanimous consent from registered holders of the outstanding Repriced Warrants, as per Canadian Securities Exchange (CSE) policies.
The CSE policies also stipulate that if the closing price of Nexus's common shares exceeds the amended exercise price by more than 25% for any ten consecutive trading days, the expiry date of the Repriced Warrants must be amended to 30 days from June 25, 2026. Nexus will announce any such change via press release, with the 30-day period commencing seven days after the end of the ten-day trading period.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) ha annunciato la modifica del prezzo di esercizio di 2.887.114 warrant di acquisto di azioni ordinarie. I warrant, inizialmente fissati a un prezzo di esercizio di $0,60 con una data di scadenza del 25 giugno 2026, saranno modificati a $0,36, con effetto immediato. Questa Modifica del Prezzo dei Warrant è soggetta al consenso unanime dei detentori registrati dei Warrant Modificati, in conformità con le politiche della Canadian Securities Exchange (CSE).
Le politiche della CSE stabiliscono anche che se il prezzo di chiusura delle azioni ordinarie di Nexus supera il prezzo di esercizio modificato di oltre il 25% per dieci giorni di negoziazione consecutivi, la data di scadenza dei Warrant Modificati deve essere cambiata a 30 giorni dopo il 25 giugno 2026. Nexus annuncerà qualsiasi cambiamento tramite comunicato stampa, con il periodo di 30 giorni che inizia sette giorni dopo la fine del periodo di negoziazione di dieci giorni.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) ha anunciado la modificación del precio de ejercicio de 2,887,114 opciones de compra de acciones ordinarias. Las opciones, inicialmente establecidas a un precio de ejercicio de $0.60 con una fecha de vencimiento del 25 de junio de 2026, serán modificadas a $0.36, con efecto inmediato. Esta Modificación del Precio de las Opciones está sujeta al consentimiento unánime de los titulares registrados de las Opciones Modificadas, según las políticas de la Canadian Securities Exchange (CSE).
Las políticas de la CSE también estipulan que si el precio de cierre de las acciones ordinarias de Nexus supera el precio de ejercicio modificado en más del 25% durante diez días de negociación consecutivos, la fecha de vencimiento de las Opciones Modificadas debe cambiarse a 30 días a partir del 25 de junio de 2026. Nexus anunciará cualquier cambio a través de un comunicado de prensa, comenzando el período de 30 días siete días después del final del período de negociación de diez días.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1)는 2,887,114개의 보통주 매수 권리증서의 가격 재조정을 발표했습니다. 원래 $0.60의 행사 가격과 2026년 6월 25일의 만료일로 설정된 이 권리증서는 즉각적으로 $0.36로 재조정됩니다. 이 권리증서 가격 재조정은 캐나다 증권 거래소(CSE) 정책에 의거하여 등록된 기존 재조정된 권리증서 보유자들의 만장일치 동의가 필요합니다.
CSE 정책에 따르면, 만약 Nexus의 보통주 폐장 가격이 수정된 행사 가격을 25% 이상 초과하여 10일 연속 거래일 동안 지속될 경우, 재조정된 권리증서의 만료일은 2026년 6월 25일부터 30일로 변경되어야 합니다. Nexus는 10일 거래 기간 종료 후 7일 이내에 보도 자료를 통해 모든 변경 사항을 발표할 것입니다.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) a annoncé la revalorisation de 2 887 114 bons de souscription d'actions ordinaires. Les bons, à l'origine fixés à un prix d'exercice de 0,60 $ avec une date d'expiration au 25 juin 2026, seront revalorisés à 0,36 $, avec effet immédiat. Cette Revalorisation des Bons est soumise à l'accord unanime des titulaires enregistrés des Bons Revalorisés, conformément aux politiques de la Canadian Securities Exchange (CSE).
Les politiques de la CSE stipulent également que si le prix de clôture des actions ordinaires de Nexus dépasse le prix d'exercice modifié de plus de 25 % pendant dix jours de négociation consécutifs, la date d'expiration des Bons Revalorisés doit être modifiée à 30 jours à compter du 25 juin 2026. Nexus annoncera tout changement éventuel par communiqué de presse, la période de 30 jours commençant sept jours après la fin de la période de négociation de dix jours.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) hat die Neufestsetzung von 2.887.114 Kaufwarrants für Stammaktien angekündigt. Die Warrants, ursprünglich zu einem Ausübungspreis von 0,60 $ mit einem Ablaufdatum vom 25. Juni 2026 festgelegt, werden sofort auf 0,36 $ neu festgesetzt. Diese Neufestsetzung der Warrants unterliegt der einstimmigen Zustimmung der registrierten Inhaber der betroffenen Warrants gemäß den Richtlinien der Canadian Securities Exchange (CSE).
Die CSE-Richtlinien besagen auch, dass, wenn der Schlusskurs der Stammaktien von Nexus den geänderten Ausübungspreis an 10 aufeinanderfolgenden Handelstagen um mehr als 25 % übersteigt, das Ablaufdatum der neu festgesetzten Warrants auf 30 Tage ab dem 25. Juni 2026 geändert werden muss. Nexus wird eine solche Änderung über eine Pressemitteilung bekannt geben, wobei der 30-tägige Zeitraum sieben Tage nach Ende der zehn Handelstage beginnt.
- Reduction of warrant exercise price from $0.60 to $0.36, potentially increasing the likelihood of warrant exercise and capital inflow
- Potential dilution of existing shareholders if warrants are exercised at the lower price
- Possible reduction in warrant expiry period from June 25, 2026 to 30 days if stock price performs well, which could pressure warrant holders
Vancouver, British Columbia--(Newsfile Corp. - October 17, 2024) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) (the "Company" or "Nexus") announces the repricing of 2,887,114 common share purchase warrants with an exercise price of
As the Warrant Repricing will result in an exercise price lower than the market price of the Company's common shares on the date the warrants were issued, CSE policies require that, if following the Warrant Repricing, for any ten consecutive trading days the closing price of the Company's common shares on the CSE exceeds the amended exercise price by more than
About Nexus Uranium Corp.
Nexus Uranium Corp. is a multi-commodity development company focused on advancing the Cree East uranium project in the Athabasca Basin and the Wray Mesa uranium-vanadium project in Utah in addition to its precious metals portfolio that includes the Napoleon gold project in British Columbia, and a package of gold claims in the Yukon. The Cree East project is one of the largest projects within the Athabasca Basin of Saskatchewan spanning 57,752 hectares (142,708 acres) and has seen over
The technical content of this news release has been reviewed and approved by Warren D. Robb, P.Geo. (BC), a Director and VP Exploration of Nexus Uranium Corp. and a Qualified Person under National Instrument 43-101.
FOR FURTHER INFORMATION PLEASE CONTACT:
Jeremy Poirier
Chief Executive Officer
info@nexusuranium.com
This news release includes certain statements and information that may constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance are forward-looking statements and contain forward-looking information, including, but not limited to, completion of the Warrant Repricing. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this news release, including, but not limited to the assumption that the holders of the Repriced Warrants will consent to the Warrant Repricing. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including, but not limited to the risk that the holders of the Repriced Warrants will not consent to the Repricing, stock market volatility and capital market fluctuations, general market and industry conditions, as well as those risk factors discussed in the Company's most recently filed management's discussion & analysis. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226971
FAQ
What is the new exercise price for Nexus Uranium Corp's (GIDMF) repriced warrants?
How many warrants are affected by Nexus Uranium Corp's (GIDMF) repricing announcement?
What is the current expiry date of Nexus Uranium Corp's (GIDMF) repriced warrants?
Under what conditions might the expiry date of Nexus Uranium Corp's (GIDMF) repriced warrants change?
